Cuando hay dudas existen marcadores complementarios, como la cistatina C
Following the positive REDEFINE 1 Phase 3 data (published June 2025, PMID: 40544433), Novo Nordisk announced plans to file regulatory applications for CagriSema for obesity in the United States (FDA), European Union (EMA), and other major markets in 20252026
People with low kidney function may need to limit the amount of protein in their diets (5)
Pharmacologic approaches to glycemic treatment: Standards of Medical Care in Diabetes2020
Your doctor can help adjust dosing, manage side effects, and monitor your overall health
You can follow these Food and Drug Administration (FDA)-approved steps to dispose of your medication in the trash: Mix your medication with an unappealing substance, like dirt or used coffee grounds